Teladoc Health [TDOC] vs Schrodinger [SDGR] Detailed Stock Comparison

Teladoc Health Inc.

NYSE
Loading...

Schrodinger Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Teladoc Health Inc. wins in 15 metrics, Schrodinger Inc. wins in 3 metrics, with 0 ties. Teladoc Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Teladoc Health Inc. Schrodinger Inc. Better
P/E Ratio (TTM) N/A 44.39 N/A
Price-to-Book Ratio 0.74 2.39 Teladoc Health Inc.
Debt-to-Equity Ratio 75.06 30.03 Schrodinger Inc.
PEG Ratio -6.16 -8.54 Teladoc Health Inc.
EV/EBITDA 38.86 -3.63 Teladoc Health Inc.
Profit Margin (TTM) -7.92% -40.36% Teladoc Health Inc.
Operating Margin (TTM) -4.20% -19.67% Teladoc Health Inc.
Return on Equity -13.93% -26.29% Teladoc Health Inc.
Return on Assets (TTM) -3.20% -13.47% Teladoc Health Inc.
Free Cash Flow (TTM) $137.33M $12.46M Teladoc Health Inc.
1-Year Return 7.00% -32.57% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 0.41 3.40 Teladoc Health Inc.
Enterprise Value $1.28B $584.24M Teladoc Health Inc.
EV/Revenue Ratio 0.51 2.28 Teladoc Health Inc.
Gross Profit Margin (TTM) 69.32% 65.68% Teladoc Health Inc.
Revenue per Share (TTM) $14 $3 Teladoc Health Inc.
Earnings per Share (Diluted) $-34.20 $-1.41 Schrodinger Inc.
Beta (Stock Volatility) 2.08 1.62 Schrodinger Inc.
Short % of Float 16.55% 26.87% Teladoc Health Inc.

Teladoc Health Inc. vs Schrodinger Inc. Stock Performance Analysis

Loading Price Chart...

TDOC
SDGR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%
Schrodinger Inc.1.04%1.39%22.18%14.96%-19.82%-18.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%
Schrodinger Inc.-32.57%-68.57%-80.48%-54.73%-54.73%-54.73%

Performance & Financial Health Analysis: Teladoc Health Inc. vs Schrodinger Inc.

MetricTDOCSDGR
Market Information
Market Cap i$1.04B$870.40M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,716,7501,739,800
90 Day Avg. Volume i4,439,2771,277,040
Last Close$7.46$14.60
52 Week Range$4.40 - $9.77$10.94 - $23.75
% from 52W High-23.64%-38.53%
All-Time High$308.00 (Feb 15, 2021)$117.00 (Feb 22, 2021)
% from All-Time High-97.58%-87.52%
Growth Metrics
Quarterly Revenue Growth0.00%-0.01%
Quarterly Earnings Growth0.00%-0.01%
Financial Health
Profit Margin (TTM) i-0.08%-0.40%
Operating Margin (TTM) i-0.04%-0.20%
Return on Equity (TTM) i-0.14%-0.26%
Debt to Equity (MRQ) i75.0630.03
Cash & Liquidity
Book Value per Share (MRQ)$7.77$4.94
Cash per Share (MRQ)$4.38$5.36
Operating Cash Flow (TTM) i$294.36M$13.90M
Levered Free Cash Flow (TTM) i$226.14M$99.98M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Teladoc Health Inc. vs Schrodinger Inc.

MetricTDOC (Apr 26, 2026)SDGR (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A44.39
Forward P/E i-6.16-8.54
PEG Ratio i-6.16-8.54
Price to Sales (TTM) i0.413.40
Price to Book (MRQ) i0.742.39
Market Capitalization
Market Capitalization i$1.04B$870.40M
Enterprise Value i$1.28B$584.24M
Enterprise Value Metrics
Enterprise to Revenue i0.512.28
Enterprise to EBITDA i38.86-3.63
Risk & Other Metrics
Beta i2.081.62
Book Value per Share (MRQ) i$7.77$4.94

Financial Statements Comparison: Teladoc Health Inc. vs Schrodinger Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTDOC (2025)SDGR (2025)
Revenue/Sales i2.53B255.87M
Cost of Goods Sold i771.59M113.26M
COGS % of Revenue i30.5%44.3%
Gross Profit i1.76B142.61M
Gross Margin i69.5%55.7%
Research & Development i277.92M173.14M
Operating Income (EBIT) i-163.40M-166.90M
Operating Margin i-6.5%-65.2%
EBITDA i260.18M-209.05M
EBITDA Margin i10.3%-81.7%
Pre-Tax Income i-235.53M-102.33M
Pre-Tax Income % of Revenue i-9.3%-40.0%
Income Tax i-35.21M939,000
Income Tax % of Revenue i-1.4%0.4%
Net Income (Profit) i-200.32M-103.27M
Profit Margin i-7.9%-40.4%

Balance Sheet & Liquidity Metrics

MetricTDOC (2025)SDGR (2025)
Cash & Equivalents i781.08M230.52M
Total Current Assets i1.12B519.27M
Total Current Assets % of Revenue i44.2%202.9%
Total Current Liabilities i404.74M189.14M
Total Current Liabilities % of Revenue i16.0%73.9%
Long-Term Debt i1.03B92.82M
Long-Term Debt % of Revenue i40.7%36.3%
Total Shareholders Equity i1.39B364.05M
Retained Earnings i-16.43B-628.81M
Retained Earnings % of Revenue i-649.4%-245.8%
Property, Plant & Equipment i42.03M114.00M

Cash Flow Statement Comparison

MetricTDOC (2025)SDGR (2025)
Operating Cash Flow i225.59M69.12M
Operating Cash Flow % of Revenue i8.9%27.0%
Capital Expenditures iN/A-1.44M
Free Cash Flow i137.33M12.46M
FCF Margin i5.4%4.9%
Debt Repayment i-550.63M-58,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTDOCSDGR
Shares Short i29.71M10.91M
Short Ratio i6.899.75
Short % of Float i16.55%26.87%
Shares Outstanding i178.32M73.68M
Float Shares i176.23M58.70M
% Held by Insiders i0.65%3.23%
% Held by Institutions i75.86%107.44%
% Held by Public i23.49%-10.67%

Dividend Analysis & Yield Comparison: Teladoc Health Inc. vs Schrodinger Inc.

MetricTDOCSDGR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A